Nurix CFO Sells Small Stake, Exercises RSUs as Analysts Lift Price Targets
Nurix Therapeutics Chief Financial Officer Hans van Houte completed two share sales totaling 3,661 shares on January 30, 2026, and on the same date acquired 11,496 shares through the exercise of restricted stock units. The transactions coincided with a flurry of analyst updates after the company's fourth-quarter 2025 earnings, during which several …